Lytix Biopharma ASLytix Biopharma AS - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Check the end of this webpage for potential risks for Lytix Biopharma AS based on industry, location and size. This assessment of Lytix Biopharma AS employs information from across the web and also from available documents by Lytix Biopharma AS. The analysis of Lytix Biopharma AS is prepared by All Street Sevva using leading machine learning.

Lytix Biopharma AS in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.4; made up of an environmental score of 6.0, social score of 6.7 and governance score of 3.4.

SDG Transparency Score for Lytix Biopharma AS 
Low
0 - 3

5.4

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Lytix Biopharma AS 
6.0

Environmental

6.7

Social

3.4

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
835Wuhan Keqian Biology Co Ltd
5.5
High
835dorsaVi Ltd
5.5
High
886Lytix Biopharma AS
5.4
High
886Avant Brands Inc
5.4
High
886Antengene Corporation Ltd
5.4
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Lytix Biopharma AS have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Lytix Biopharma AS disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Lytix Biopharma AS report the average age of the workforce?

LockedSign up for free to unlock

Does Lytix Biopharma AS reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Lytix Biopharma AS disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Lytix Biopharma AS disclose cybersecurity risks?

LockedSign up for free to unlock

Does Lytix Biopharma AS offer flexible work?

LockedSign up for free to unlock

Does Lytix Biopharma AS have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Lytix Biopharma AS disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Lytix Biopharma AS conduct supply chain audits?

LockedSign up for free to unlock

Does Lytix Biopharma AS disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Lytix Biopharma AS conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Lytix Biopharma AS disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Lytix Biopharma AS disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Lytix Biopharma AS disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Lytix Biopharma AS disclose water use targets?

LockedSign up for free to unlock

Does Lytix Biopharma AS have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Lytix Biopharma AS have a product recall in the last two years?

LockedSign up for free to unlock

Does Lytix Biopharma AS disclose incidents of discrimination?

LockedSign up for free to unlock

Does Lytix Biopharma AS allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Lytix Biopharma AS issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Lytix Biopharma AS disclose parental leave metrics?

LockedSign up for free to unlock

Does Lytix Biopharma AS disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Lytix Biopharma AS disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Lytix Biopharma AS disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Lytix Biopharma AS support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Lytix Biopharma AS disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Lytix Biopharma AS reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Lytix Biopharma AS involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Lytix Biopharma AS disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Lytix Biopharma AS disclose its waste policy?

LockedSign up for free to unlock

Does Lytix Biopharma AS report according to TCFD requirements?

LockedSign up for free to unlock

Does Lytix Biopharma AS disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Lytix Biopharma AS disclose energy use targets?

LockedSign up for free to unlock

Does Lytix Biopharma AS disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Lytix Biopharma AS have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Lytix Biopharma AS
These potential risks are based on the size, segment and geographies of the company.

Lytix Biopharma ASA, a clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in Norway. Its lead product candidate is LTX-315, an oncolytic molecule that is developed for intratumoral injections, is designed for the local treatment of solid tumors that is in Phase II clinical trials. The company's products also include LTX-401, an oncolytic molecule for targeting deep-seated lesions, such as liver cancer and is in a preclinical phase. It has a strategic partnership with Aurelius Biotherapeutics LLC to investigate and develop LTX-122 for the veterinary medicine market. The company was founded in 2003 and is based in Oslo, Norway.

Sorry!

Failed to process!